MYB and acute myeloid leukemia: Screening of synthetic 3,4,5-trimethoxyphenyl derivatives identified the tubulin-binding naphthopyran BCR-TMP as a strong inhibitor of MYB activity with high antiproliferative activity against MLL-AF9 transformed AML cells and patient-derived ACC cells.